AcelRx Pharmaceuticals, Inc. announced the appointment of Gina Ford, RPh to the role of Vice President of Commercial Strategy. Ms. Ford has worked with AcelRx as a consultant from 2013 to the present and has been instrumental in the development of a commercial strategy for Zalviso (sufentanil sublingual tablet system). As VP Commercial Strategy, Ms. Ford will be responsible for developing the commercial plan for ARX-04 in the U.S., Europe and other geographies.

Before joining the AcelRx management team, Ms. Ford was principal and sole proprietor of One Joule.